Biogen to consolidate operations in MIT’s first Kendall Common building | MIT News | Massachusetts Institute of Technology
Biogen announced that it will centralize operations in a new facility at 75 Broadway in MIT’s Kendall Common development. The move, to take place in 2028, highlights the company’s commitment to Cambridge, Massachusetts, and the regional innovation ecosystem — a wellspring of biomedical advances.